Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Claudio Sollaci"'
Publikováno v:
Revista Brasileira de Ortopedia
Abstract Objective Enchondromas are the commonest tumors of the bones of the hand. Treatment approaches vary. The present article presents the characteristics of the tumors, diagnostic methods, and treatments. Methods We discuss the approach used in
Externí odkaz:
https://doaj.org/article/6f75bedc7dae4ab7ab62ac293ba04cd2
Autor:
Bernardo Jose Alves Ferreira Martins, Isabel Cristina Soares Brandao, Claudio Sollaci, Marcio de Mendonça Cardoso, Isabela Werneck da Cunha, Ricardo Karam Kalil, Francineide Sadala de Souza, Ricardo de Amoreira Gepp
Publikováno v:
Journal of Neuropathology & Experimental Neurology.
Neuromuscular choristoma (NMC) are lesions of the peripheral nervous system characterized by an admixture of skeletal muscle fibers and nerves fascicles that are frequently associated with desmoid fibromatosis (DF). Mutations in CTNNB1, the gene for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1acf0f258c71df3ef688b7fa1e4597f1
https://doi.org/10.1093/jnen/nlab106
https://doi.org/10.1093/jnen/nlab106
Publikováno v:
Revista Brasileira de Ortopedia. 54:714-720
Resumo Objetivo Os encondromas são os tumores mais comuns dos ossos da mão, com uma grande variedade de abordagens terapêuticas. O presente artigo apresenta as características dos tumores, métodos diagnósticos e tratamentos. Métodos Discutimos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ad2969f3c588feb2cb2d4d63b592c76f
https://doi.org/10.1055/s-0039-1697970
https://doi.org/10.1055/s-0039-1697970
Autor:
Reinaldo I. Takata, Jaime M. Brum, Savana Camilla Lima Santos, Claudio Sollaci, Carlos E. Speck-Martins, Isabela M. P. O. Rizzo
Publikováno v:
Molecular Genetics & Genomic Medicine
Background Multiple osteochondromas is a dysplasia characterized by growth of two or more osteochondromas. It is genetically heterogeneous, caused by pathogenic variants in EXT1 or EXT2 genes in 70%–90% of patients. The EXT1 is more often mutated t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c14091fb7278e7dec05bbb6e4bdd5b8
https://pubmed.ncbi.nlm.nih.gov/29529714
https://pubmed.ncbi.nlm.nih.gov/29529714